Splenic switch-off: A tool to assess stress adequacy in adenosine perfusion cardiac MR imaging

Radiology

Volumn 276, Issue 3, 2015, Pages 732-740

  Manisty, Charlotte ^a   Ripley, David P ^b   Herrey, Anna S ^a   Captur, Gabriella ^a   Wong, Timothy C ^c   Petersen, Steffen E ^d   Plein, Sven ^b   Peebles, Charles ^e   Schelbert, Erik B ^c   Greenwood, John P ^b   Moon, James C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BIOLOGICAL MARKER; DOBUTAMINE; REGADENOSON; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEART PERFUSION; HEART STRESS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPLEEN; SPLENIC SWITCH OFF; ADOLESCENT; CARDIAC IMAGING; COMPARATIVE STUDY; DIAGNOSTIC USE; EXERCISE TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PERFUSION; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADENOSINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC IMAGING TECHNIQUES; DOBUTAMINE; EXERCISE TEST; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PERFUSION; PURINES; PYRAZOLES; RETROSPECTIVE STUDIES; SPLEEN; YOUNG ADULT;

EID: 84940825821     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142059     Document Type: Article

References (28)

1. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012; 379(9814):453-460.
2. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 2013;34(10):775-781.
3. Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010;12(1):29.
4. Plein S, Kidambi A, Sourbron S, et al. Associated factors for a false negative cardiovascular magnetic resonance perfusion study: a CE-MARC substudy. J Cardiovasc Magn Reson 2013;15(Suppl 1):P214.
5. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15(1):91.
6. Hage FG, Dean P, Bhatia V, Iqbal F, Heo J, Iskandrian AE. The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease. Am Heart J 2011;162(2):356-362.
7. Norlén K. Central and regional haemodynamics during controlled hypotension produced by adenosine, sodium nitroprusside and nitroglycerin. Studies in the pig. Br J Anaesth 1988;61(2):186-193.
8. Mishra RK, Dorbala S, Logsetty G, et al. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. J Am Coll Cardiol 2005;45(4):553-558.
9. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99(6):763-770.
10. Bettencourt N, Chiribiri A, Schuster A, et al. Cardiac magnetic resonance myocardial perfusion imaging for detection of functionally significant obstructive coronary artery disease: a prospective study. Int J Cardiol 2013;168(2):765-773.
11. Greenwood JP, Maredia N, Radjenovic A, et al. Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study. Trials 2009;10:62.
12. Karamitsos TD, Ntusi NA, Francis JM, Holloway CJ, Myerson SG, Neubauer S. Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:66.
13. Chen J, Einstein AJ, Fazel R, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol 2010;56(9):702-711.
14. Walker S, Girardin F, McKenna C, et al. Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 2013;99(12):873-881.
15. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009;54(19):1747-1762.
16. Reyes E, Stirrup J, Roughton M, D'Souza S, Underwood SR, Anagnostopoulos C. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study. J Nucl Med 2010;51(7):1036-1043.
17. Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31(7):1540-1546.
18. Reyes E, Loong CY, Harbinson M, Donovan J, Anagnostopoulos C, Underwood SR. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll Cardiol 2008; 52(24):2008-2016.
19. Banko LT, Haq SA, Rainaldi DA, et al. Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening. Am J Cardiol 2010; 105(10):1474-1479.
20. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006;295(10):1135-1141.
21. Culm-Merdek KE, von Moltke LL, Harmatz JS, Greenblatt DJ. Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics. Br J Clin Pharmacol 2005;60(5):486-493.
22. van Lambalgen AA, van Kraats AA, Mulder MF, van den Bos GC, Teerlink T, Thijs LG. Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats. J Crit Care 1993;8(2):117-127.
23. Rooney MW, Crystal GJ, Salem MR, Paulissian R. Influence of nifedipine on systemic and regional hemodynamics during adenosine-induced hypotension in dogs. Anesth Analg 1989;68(3):261-269.
24. Hancock DL, Coupar IM. Functional characterization of the adenosine receptor mediating inhibition of intestinal secretion. Br J Pharmacol 1995;114(1):152-156.
25. Hamza SM, Kaufman S. Role of spleen in integrated control of splanchnic vascular tone: physiology and pathophysiology. Can J Physiol Pharmacol 2009;87(1):1-7.
26. Fozard JR, Milavec-Krizman M. Contraction of the rat isolated spleen mediated by adenosine A1 receptor activation. Br J Pharmacol 1993;109(4):1059-1063.
27. Chiribiri A, Hautvast GLTF, Lockie T, et al. Assessment of coronary artery stenosis severity and location: quantitative analysis of transmural perfusion gradients by high-resolution MRI versus FFR. JACC Cardiovasc Imaging 2013;6(5):600-609.
28. Costa MA, Shoemaker S, Futamatsu H, et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 2007;50(6):514-522.